Fecal Microbiota Transplant: Clinical Trials

34 trials of Fecal Microbiota Transplant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 5 not yet recruiting, 5 unknown, 4 terminated. 15 Phase 1, 10 Phase 2, 9 Not applicable, 2 Early Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 115Completed 9, Not yet recruiting 2, Terminated 2, Enrolling by invitation 1, Recruiting 1
Phase 210Completed 6, Terminated 2, Active not recruiting 1, Unknown 1
Not applicable9Not yet recruiting 3, Unknown 3, Withdrawn 2, Completed 1
Early Phase 12Completed 1, Unknown 1
Phase 42Completed 2
Phase 31Completed 1

Follow Fecal Microbiota Transplant: new trials by email Literature Review of Fecal Microbiota Transplant trials Research Report on Fecal Microbiota Transplant

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
Fecal Microbiota Transplant - Parkinson Disease
Phase 1Not yet recruitingProgenaBiome102027-07-012026-10-09
Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders
Fecal Microbiota Transplant - Autism, Autism Spectrum Disorder
Phase 1Not yet recruitingProgenaBiome102027-05-012026-09-18
Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae
Fecal microbiota transplant, Sham fecal microbiota transplant - Carbapenem-Resistant Enterobacteriaceae Infection, Fecal Microbiota Transplantation
Not applicableNot yet recruitingThe University of Hong Kong802026-11-012026-05-13
Fecal Microbiota Transplant for Anorexia Nervosa
Fecal Microbiota Transplant, Placebo - Anorexia Nervosa Restricting Type, Anorexia Nervosa
Not applicableNot yet recruitingHamilton Health Sciences Corporation202026-06-012026-05-27
Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth
Fecal Microbiota Transplant - Small Intestinal Bacterial Overgrowth
Phase 1RecruitingMcMaster Children's Hospital202024-03-112025-08-21
Preterm Infant Intestinal Microbiota Development and Maternal Fecal Transplant
Fecal microbiota transplant - Microbial Colonization
Not applicableNot yet recruitingOtto Helve362024-02-012024-02-15
Efficacy and Safety of Fecal Microbiota Transplant for Secondary Prophylaxis of Hepatic Encephalopathy
Standard Medical Treatment, Fecal Microbiota Transplant - Hepatic Encephalopathy
Not applicableUnknownInstitute of Liver and Biliary Sciences, India662022-01-312022-02-08
FMT In High-Risk Acute GVHD After ALLO HCT
Fecal Microbiota Transplant - Acute Graft-Versus-Host Disease (Gvhd) Grade, Hematopoietic Cell Transplantation
Phase 1CompletedMassachusetts General Hospital102021-06-182024-03-07
Transfer of Feces in Ulcerative Colitis 2
Fecal microbiota transplant - Ulcerative Colitis, Ulcerative Colitis Flare
Phase 2CompletedAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)852020-06-122026-03-20
FMT in Children With Autism and Gastrointestinal Symptoms
FMT, FMT - placebo - Children With Autism
Not applicableUnknownAssaf Harofeh MC502020-02-012020-02-05
To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure
Standard Medical Treatment, Fecal Microbiota Transplant, Placebo - Acute Liver Failure
Not applicableWithdrawnInstitute of Liver and Biliary Sciences, India2020-02-012019-11-05
Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease
Fecal Microbiota Transplant - Alzheimer Disease
Phase 1TerminatedUniversity of Wisconsin, Madison52019-11-142020-07-24
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
Fecal microbiota transplant, Pembrolizumab, Enzalutamide - Prostate Cancer, Prostate Cancer Metastatic
Phase 2UnknownJulie Graff, MD322019-10-302022-06-23
PediCRaFT: Pediatric Crohn's Disease Fecal Transplant Trial
MICROBIOTA, PLACEBO - Crohn Disease, Pediatric Crohns Disease
Phase 1CompletedMcMaster Children's Hospital172018-12-012023-10-19
A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma
Fecal Microbiota Transplant - Mesothelioma
Early Phase 1CompletedProgenaBiome12018-09-182019-09-23
Fecal Microbiota Transplant
Fecal Microbiota Transplant - Clostridium Difficile Infection
Phase 4CompletedMethodist Health System242018-06-052026-03-24
Fecal Microbiota Transplantation (FMT) for MDRO UTI
Fecal microbiota transplant - Urinary Tract Infections
Phase 1 / Phase 2CompletedWashington University School of Medicine12018-02-082022-03-18
Microbiota Transfer Therapy for Adults With Autism Spectrum Disorder (ASD) Who Have Gastrointestinal Disorders
Vancomycin, MoviPrep, Full Spectrum Microbiota - Autism Spectrum Disorder, Gastrointestinal Disorder
Phase 2Active not recruitingArizona State University552018-01-042023-01-09
Evaluating the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplant in Peanut Allergic Patients
Fecal Microbiota Capsule - Peanut Allergy
Phase 1CompletedRima Rachid152017-03-032026-10-08
EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant
fecal microbiota transplant - C.Difficile Colitis
Not applicableWithdrawnMilton S. Hershey Medical Center2016-09-152017-11-27

Showing 20 of 34. Sign in to see all of them.

Conditions studied

Colitis, Ulcerative (5)  ·  Clostridium Infections (4)  ·  Autism Spectrum Disorder (3)  ·  Crohn Disease (3)  ·  Inflammatory Bowel Diseases (3)  ·  Communicable Diseases (2)  ·  Hepatic Encephalopathy (2)  ·  Alzheimer Disease (1)  ·  Anorexia (1)  ·  Anorexia Nervosa (1)  ·  Autistic Disorder (1)  ·  Colitis (1)  ·  Diarrhea (1)  ·  Dysbiosis (1)  ·  Enterocolitis, Pseudomembranous (1)

Sponsors

University of Alberta (4)  ·  Institute of Liver and Biliary Sciences, India (3)  ·  Massachusetts General Hospital (3)  ·  ProgenaBiome (3)  ·  McMaster Children's Hospital (2)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1)  ·  Arizona State University (1)  ·  Assaf Harofeh MC (1)  ·  Baylor College of Medicine (1)  ·  Centre d'Investigation Clinique et Technologique 805 (1)  ·  Endeavor Health (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Judith Kelsen (1)  ·  Julie Graff, MD (1)  ·  McMaster University (1)

Countries

United States (17)  ·  Canada (7)  ·  India (3)  ·  Finland (1)  ·  France (1)  ·  Israel (1)  ·  Netherlands (1)

Top investigators

Dina Kao, MD (3)  ·  Elizabeth Hohmann, MD (2)  ·  Barbara Bendlin, PhD (1)  ·  Becky Smith, MD (1)  ·  Benjamin Davido, MD, MS (1)  ·  Dr Abhinav Verma, MD (1)  ·  Erik Dubberke, MD, MSPH (1)  ·  James B Adams, PhD (1)  ·  Jennifer Grant, MD (1)  ·  Jennifer L Couturier, MD, MSc (1)  ·  Judith Kelsen, MD (1)  ·  Julie N Graff, MD (1)  ·  Ka Shing Cheung (1)  ·  Muhammad Memon, MD (1)  ·  Nikhil Pai, BSc, CNSC, MD, FRCPC (1)

Results publications

PMID 29183074, PMID 31784432, PMID 33007265, PMID 33463542, PMID 34238227, PMID 38471063, PMID 40568349, PMID 42009386, PMID 42086265

NIH funding

2014 (1)